CTIP Announces 2024 Finalists for Catalyzing Pediatric Innovation Annual Grant Competition
CHICAGO, ILLINOIS – JUNE 11, 2024 – Children have long been an underserved population in the technology space, often having to deal with medical devices that were never designed for them and lack of access to diagnostics and therapeutics that meet their specific needs. The Consortium for Technology & Innovation in Pediatrics (CTIP) aims to change that by supporting pediatric device innovators from concept to commercialization through funding, advising, networking, and advocacy.
Now in its eighth year, the CTIP Catalyzing Pediatric Innovation Grant remains competitive. CTIP received over 80 Letters of Intent for our 2024 Catalyzing Pediatric Innovation Grant and is excited to share the many innovative products and concepts submitted for application in the pediatric medical device space.
By the Numbers
Over 80 applications from 24 states, including 36% from California
All device classes:
26% Class I
52% Class II
6% Class III
16% TBD
37 different Pediatric Subspecialties
CTIP is committed to diversity, equity, and inclusion. We believe in supporting individuals from diverse and historically underrepresented backgrounds in the fields of science, technology, engineering, and business. By application, members of the company’s founding or executive team (for example: CEO, COO, CFO) identify as:
61% Women
61% Person of Color/Underrepresented minority in STEM or Business
13% LGBTQ+ individual
8% Person with Disability(ies)
1% Veteran
The 2024 finalists, announced June 11, are as follows:
AVaTAR stands as a groundbreaking surgical method and set of medical devices for pediatric aortic or pulmonary valve reconstruction using autologous tissue.
LinkedIn: AVaTAR MedTech
Eysz aims to revolutionize pediatric care with its Brain Health Platform, offering cutting-edge digital tools to help physicians diagnose and manage neurological and psychiatric symptoms in children, bridging the gap as pediatric subspecialist access dwindles.
LinkedIn: Eysz
Soft Wearable System to Improve Cardiovascular Home Monitoring of Interstage Infants with Single Ventricle Heart Disease
The soft wearable system improves the difficult and high-risk interstage home monitoring program for single ventricle patients by broadening observable biosignals, facilitating communication between the home and hospital, and integrating a patient-specific red flag alert system for timely care, improving patient outcomes.
Biomotum developed a smart adjustable stiffness AFO that can adapt to different terrains and walking activities to address the limitations in existing single-stiffness AFO designs.
LinkedIn: Biomotum
Co-Development and Validation of Momentum Spine
Momentum Spine is a AI-based mobile imaging platform for the remote management of spinal deformities.
LinkedIn: Health Momentum
‘BENGI – NANO’ for Improved Neonatal Ventilation
'BENGI – NANO' is developed as a novel and innovative pediatric neonatal ventilation technology, which addresses unique respiratory challenges of neonates, infants, and children, by providing precise and responsive guidance for manual ventilation which improves safety and outcomes in pediatric respiratory care.
LinkedIn: https://www.linkedin.com/in/j-steven-alexander-ph-d-335a843/
Creating an Artificial Right Atrium to Improve Mechanical Circulatory Support for Patients with Failing Fontan Circulation
The artificial right atrium establishes a reservoir to allow for mechanical support in pediatric patients born with single ventricle physiology.
LinkedIn: https://www.linkedin.com/in/cynthia-herrington-37633475/
Exhalos: Breath monitor for necrotizing enterocolitis
Exhalos is building a breath monitor for early-stage necrotizing enterocolitis in preterm neonates.
LinkedIn: https://www.linkedin.com/in/julianaperl/
The VP.S ENCORE® PEDS™, an innovative hypothermic machine perfusion device, is revolutionizing organ transplantation by prioritizing simplicity, ease of use, and cost-effectiveness to accommodate severely underserved pediatric populations.
LinkedIn: Vascular Perfusion Solutions
EDNA – Early Detection Neuromotor Assessment
EDNA is a medical device software that uses machine learning to detect subtle patterns of movement variability in infants to provide insights to the infant's nervous system and help inform clinical workflow for physicians.
MyTrach Innovations, LLC
An integrated tracheostomy tube monitoring and alerting apparatus for patients with an artificial airway. This system can continually monitor and detect one or more physiological parameters such as airflow and carbon dioxide levels. When airflow falls below a predetermined threshold or carbon dioxide levels exceed a predetermined threshold, the caregiver can be alerted to identify blockage in the tracheostomy tube due to dislodgement and action can be taken quickly to avoid hypoxic brain damage and death.
___
Stay up to date with the latest news from CTIP by signing up for our newsletter.
For more updates from CTIP about pediatric MedTech, follow us on LinkedIn and X.
Find us online at www.ctipmedtech.org.
The Consortium for Technology & Innovation in Pediatrics (CTIP) is an FDA-funded pediatric MedTech accelerator centered at Lurie Children’s Hospital (LCH) and Children's Hospital Los Angeles (CHLA). Our goal is to facilitate the development, production, and distribution of pediatric medical devices by identifying companies working in the space and providing advice, networking, and direct and indirect financial support on the road to commercialization.
Questions? Please contact us at info@ctipmedtech.org.